Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?

about

Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?

Item

http://www.wikidata.org/entity/Q38693441

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Familial Presenilin Mutations ...... hemical Equivalence Justified?

@en

type

Item

label

Familial Presenilin Mutations ...... hemical Equivalence Justified?

@en

prefLabel

Familial Presenilin Mutations ...... hemical Equivalence Justified?

@en

P1476

Familial Presenilin Mutations ...... hemical Equivalence Justified?

@en

P2093

Alex E Roher

http://www.w3.org/2001/XMLSchema#string

Chera L Maarouf

http://www.w3.org/2001/XMLSchema#string

Tyler A Kokjohn

http://www.w3.org/2001/XMLSchema#string

P2860

FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Aβ

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers

Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue

Skeletal and CNS defects in Presenilin-1-deficient mice

Proteolytic processing of Alzheimer's β-amyloid precursor protein

Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene

Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy

Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network

P304

645-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-150757

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26757189

http://www.w3.org/2001/XMLSchema#string